Literature DB >> 1583144

Assay of urease-inhibiting activity in serum from children infected with Helicobacter pylori.

J E Thomas1, A M Whatmore, M A Kehoe, A W Skillen, M R Barer.   

Abstract

In order to provide a basis for obtaining further information concerning the host response to Helicobacter pylori urease, four assay methods for detecting urease-inhibiting activity in serum were examined. A quantitative assay, established in a COBAS BIO centrifugal fast analyzer and based on detection of the consumption of NADH by glutamate dehydrogenase stimulated by ammonia production, was considered most suitable for large-scale serological work. Serum samples from 63 children (aged 5 to 16 years), 28 of whom had seropositive H. pylori gastritis, were assayed. One of the serum samples in this latter group showed significant inhibitory activity. This serum sample was one of 13 in the seropositive group known to bind to urease antigen. It showed no inhibitory activity against Bacillus pasteurii or jack bean urease. Protein A binding and heat treatment indicated that the inhibitory activity was immunoglobulin G mediated. The patient from whom this sample was collected showed no distinctive features in his illness. The COBAS BIO analyzer-based urease inhibition assay provides a new tool for studying one aspect of the host response to H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1583144      PMCID: PMC265281          DOI: 10.1128/jcm.30.5.1338-1340.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

Review 1.  Microbial ureases: significance, regulation, and molecular characterization.

Authors:  H L Mobley; R P Hausinger
Journal:  Microbiol Rev       Date:  1989-03

2.  Rapid screening for urease inhibitors.

Authors:  J M Hamilton-Miller; R A Gargan
Journal:  Invest Urol       Date:  1979-03

3.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

4.  Cytopathic effects of Campylobacter pylori urease.

Authors:  M R Barer; T S Elliott; D Berkeley; J E Thomas; E J Eastham
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

5.  Campylobacter pylori urease: a new serological test.

Authors:  J C Dent; C A McNulty; J S Uff; M W Gear; S P Wilkinson
Journal:  Lancet       Date:  1988-04-30       Impact factor: 79.321

6.  Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.

Authors:  J E Crabtree; J D Taylor; J I Wyatt; R V Heatley; T M Shallcross; D S Tompkins; B J Rathbone
Journal:  Lancet       Date:  1991-08-10       Impact factor: 79.321

7.  Serodiagnosis of Helicobacter pylori infection in childhood.

Authors:  J E Thomas; A M Whatmore; M R Barer; E J Eastham; M A Kehoe
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.